Jeffrey F Scott1, Ruzica Z Conic2, Cheryl L Thompson3, Meg R Gerstenblith2, Jeremy S Bordeaux2. 1. Department of Dermatology, University Hospitals Cleveland Medical Center and Case Western Reserve University, Cleveland, Ohio. Electronic address: jeffrey.scott@uhhospitals.org. 2. Department of Dermatology, University Hospitals Cleveland Medical Center and Case Western Reserve University, Cleveland, Ohio. 3. Department of Family Medicine and Community Health, University Hospitals Cleveland Medical Center and Case Western Reserve University, Cleveland, Ohio.
Abstract
BACKGROUND: Melanoma of unknown primary (MUP) is incompletely described on a population level. OBJECTIVE: We sought to characterize stage IV MUP in a population-based cancer registry. METHODS: We developed a novel search algorithm to identify cases of stage IV MUP in the Surveillance, Epidemiology, and End Results 18 registries from 1973 to 2014. Cases of stage IV melanoma of known primary (MKP) served as a comparison group. Age-standardized incidence rates, demographic characteristics, adjusted disease-specific survival, and Cox proportional hazard models were calculated for MUP and MKP. RESULTS: A total of 322 stage IV MUP cases and 12,796 stage IV MKP cases were identified in Surveillance, Epidemiology, and End Results 18 registries from 1973 to 2014. The incidence of stage IV MUP is increasing, particularly for patients younger than 30 years of age. In multivariate analyses, age older than 50 and a lack of surgical treatment were negative prognostic factors for stage IV MUP. Relative survival, but not 5-year adjusted disease-specific survival, was higher for stage IV MUP than for MKP. LIMITATIONS: Limitations include the retrospective study design and possible misclassification of MUP. CONCLUSIONS: The incidence of stage IV MUP is increasing, and stage IV MUP shares similar prognostic factors with stage IV MKP, including age and surgical treatment.
BACKGROUND:Melanoma of unknown primary (MUP) is incompletely described on a population level. OBJECTIVE: We sought to characterize stage IV MUP in a population-based cancer registry. METHODS: We developed a novel search algorithm to identify cases of stage IV MUP in the Surveillance, Epidemiology, and End Results 18 registries from 1973 to 2014. Cases of stage IV melanoma of known primary (MKP) served as a comparison group. Age-standardized incidence rates, demographic characteristics, adjusted disease-specific survival, and Cox proportional hazard models were calculated for MUP and MKP. RESULTS: A total of 322 stage IV MUP cases and 12,796 stage IV MKP cases were identified in Surveillance, Epidemiology, and End Results 18 registries from 1973 to 2014. The incidence of stage IV MUP is increasing, particularly for patients younger than 30 years of age. In multivariate analyses, age older than 50 and a lack of surgical treatment were negative prognostic factors for stage IV MUP. Relative survival, but not 5-year adjusted disease-specific survival, was higher for stage IV MUP than for MKP. LIMITATIONS: Limitations include the retrospective study design and possible misclassification of MUP. CONCLUSIONS: The incidence of stage IV MUP is increasing, and stage IV MUP shares similar prognostic factors with stage IV MKP, including age and surgical treatment.
Authors: John A Curtin; Jane Fridlyand; Toshiro Kageshita; Hetal N Patel; Klaus J Busam; Heinz Kutzner; Kwang-Hyun Cho; Setsuya Aiba; Eva-Bettina Bröcker; Philip E LeBoit; Dan Pinkel; Boris C Bastian Journal: N Engl J Med Date: 2005-11-17 Impact factor: 91.245
Authors: B Schlagenhauff; W Stroebel; U Ellwanger; F Meier; C Zimmermann; H Breuninger; G Rassner; C Garbe Journal: Cancer Date: 1997-07-01 Impact factor: 6.860
Authors: Anne F Pfeil; Ulrike Leiter; Petra G Buettner; Thomas K Eigentler; Benjamin Weide; Friedegund Meier; Claus Garbe Journal: Melanoma Res Date: 2011-06 Impact factor: 3.599
Authors: Friederike Egberts; Sandra Krüger; Hans M Behrens; Inka Bergner; Giorgios Papaspyrou; Jochen A Werner; Ibrahim Alkatout; Jochen Haag; Axel Hauschild; Christoph Röcken Journal: Melanoma Res Date: 2014-04 Impact factor: 3.599
Authors: Sarah A Weiss; Joseph Han; Farbod Darvishian; Jeremy Tchack; Sung Won Han; Karolina Malecek; Michelle Krogsgaard; Iman Osman; Judy Zhong Journal: J Transl Med Date: 2016-10-19 Impact factor: 5.531
Authors: D Verver; Aam van der Veldt; Acj van Akkooi; C Verhoef; D J Grünhagen; W J Louwman Journal: Int J Cancer Date: 2019-03-20 Impact factor: 7.396
Authors: Danielle Verver; Dirk J Grünhagen; Alexander C J van Akkooi; Maureen J B Aarts; Franchette W P J van den Berkmortel; Alfonsus J M van den Eertwegh; Jan Willem B de Groot; Marye J Boers-Sonderen; John B A G Haanen; Geke A P Hospers; Ellen Kapiteijn; Djura Piersma; Rozemarijn S van Rijn; Karijn P M Suijkerbuijk; Albert J Ten Tije; Gerard Vreugdenhil; Cornelis Verhoef; Astrid A M van der Veldt Journal: Cancer Immunol Immunother Date: 2021-03-27 Impact factor: 6.968